◆ 会议时间：2023年12月7日至9日
◆ 会议地点：美国 洛杉矶Los Angeles

◆ 会议简介：

2023年第21届世界胰岛素抵抗、糖尿病和心血管疾病大会(WCIRDC)将于2023年12月7日至9日在美国洛杉矶举行。世界胰岛素抵抗、糖尿病和心血管疾病大会(WCIRDC)是由代谢内分泌教育基金会(MEEF)主办的一个独特的多学科会议。WCIRDC是首屈一指的致力于糖尿病、肥胖、脂质、心血管疾病（CVD）和能量平衡宣的全球会议，并将基础研究与临床实践联系起来，预计有500余名代表参加本次会议。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)

21st Annual World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)

Date: December 7-9, 2023
Venue: Hilton Universal Hotel, Los Angeles, CA, USA

摘要征文投稿：

General Submission Deadline: November 1, 2023

点此提交摘要>>>Submit Abstract>>>

​View Sample Abstract Submission

Accepted Abstracts, submitted by registered participants, will be published in Metabolism.

Accepted submissions get 40% off registration fees and the opportunity to present at the Abstract Hall.

Top Abstracts will be selected for oral presentation at the meeting.

The committee may consider Late Breaking Abstracts for oral presentation.

Top Abstracts will receive awards and cash prizes.

***ATTN: To be eligible for publishing, you must be a registered participant of the 21st WCIRDC.

Abstract Submission & Topics

Clinical aspects of insulin resistance in childhood, adolescence, and/or adulthood pertaining to:

Diabetes, obesity, dyslipidemia, hypertension, cardiovascular disease, malignancy, liver disease, renal disease, gonadal dysfunction, and sleep disorders such as obstructive sleep apnea.

Basic science:

Mechanisms of insulin resistance, inflammation, endothelial and vascular dysfunction, metabolic dysfunction of centers such as the beta cell, adipocyte, gut, and brain.

Guidelines:

Abstracts should address either clinical or basic science aspects of insulin resistance, in fields such as diabetes, obesity, and cardiovascular disease.  Investigations of overall pathophysiology and/or effects on key metabolic centers such as the beta cell, adipocyte, gut, and brain would be of interest, as would be studies of inflammation and endothelial or other vascular dysfunction. Clinical topics may include any aspect of insulin resistance in childhood, adolescence, and/or adulthood concerning the causation and/or natural history of obesity, diabetes, hypertension, dyslipidemia, cardiovascular disease, renal disease, gonadal dysfunction (including both PCOS and male hypogonadism), gestational diabetes, other endocrine abnormality, liver disease (NAFLD), malignancy, and sleep disorders such as obstructive sleep apnea.

The interests of the Congress include multi-hormonal aspects of obesity, incretins, and other gut hormonal contributions to energy balance, and circadian rhythm as it relates to these metabolic mechanisms. Basic science studies should include those with a specific relationship to insulin action and its regulation at the cellular, organ, or whole-body level.

To demonstrate their conformity to this guideline, authors are encouraged to include a brief clarification of the relationship of their topic to insulin resistance and/or to the above metabolic processes.

Abstract Poster Presentations

Abstracts may be submitted for a poster presentation. If selected for poster presentation, the author or presenter is required to register for the congress and to be present during the poster sessions.

The presenter in attendance must be one of the authors listed on the abstract. 

Abstract Oral Presentations

6 of the highest-ranking abstracts will be selected for the Abstract Oral Presentation Session - please view the agenda for the dates and times of the oral presentation session. In some cases, the committee may consider Late-Breaking Abstracts for oral presentation. The authors of the winning abstracts will present their research findings in a 10-minute presentation, followed by 5 minutes of Q&A. If selected, an author is required to register for the meeting and to be prepared with a PowerPoint presentation. Oral presenters who have an interest or involvement in selling a technology, program, product, and/or service to healthcare professionals must submit an official disclosure document to be considered for and to present their work at the abstract oral session.

Top Abstract Awards

Awards will be given to the highest-ranking abstracts. The award levels are: Gold, Silver, Bronze, and honorable mentions and are chosen from the Abstract Oral Winners. The top three winners of  WCIRDC Abstract Oral Presentation will be receiving a fast track, by the Journal Metabolism, should they submit their full papers within 60 days from the day of their oral abstract presentation at the 20th WCIRDC. The paper will be Peer reviewed, as such acceptance is not guaranteed. Metabolism - Impact Factor 13.94- Editor in Chief: Christos Mantzoros, MD, PhD 

In addition:

Scientific materials presented at the 21th Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (2023) must not have been published or presented before December 7, 2023, other than in abstract form.

1. All abstracts must be submitted electronically on a Microsoft Word document of no more than 250 words. Please do not submit any graphs, tables, figures, or references (No PDF documents will be accepted, or any submissions by fax or mail). For sample formatting, please click here.

2. All materials must arrive on or before the abstract deadline noted above.

3. Notification for acceptance will be e-mailed as soon as the committee accepts the abstract.

4. Authorship on multiple abstracts is permitted.

5. All submitted materials will be graded by the scientific planning committee, The International Committee for Insulin Resistance.

6. If an author wishes to make changes or to withdraw their abstract, they must contact the WCIRDC team no later than November 1, 2023. WCIRDC cannot guarantee that any change or withdrawal requests submitted after this date will be accommodated. All requests should be submitted via e-mail to info@tmioa.com

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。